Vimarsana
Biggest News Aggregation in the World

Page 47 - Pharma Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Group Today - Breaking & Trending Today

VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis - Vimarsana News

VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis

VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis ·         First orally administered therapy for the treatment of the two main types of ANCA-associated vasculitis approved in Europe·      &...

Vifor: VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis - Vimarsana News

Vifor: VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis

First orally administered therapy for the treatment of the two main types of ANCA-associated vasculitis approved in Europe First launches expected in H1 2022 Regulatory News: Vifor Fresenius

Global Professional Acne Medication Market (2022 to 2030) - Opportunity Analysis and Industry Forecast - Vimarsana News

Global Professional Acne Medication Market (2022 to 2030) - Opportunity Analysis and Industry Forecast

/PRNewswire/ -- The "Professional Acne Medication Market by Distribution Channel, by Acne Type, Therapeutic Class, by Formulation: Global Opportunity Analysis...

Global Professional Acne Medication Market (2022 to 2030) - Opportunity Analysis and Industry Forecast - Vimarsana News

Global Professional Acne Medication Market (2022 to 2030) - Opportunity Analysis and Industry Forecast

/PRNewswire/ -- The "Professional Acne Medication Market by Distribution Channel, by Acne Type, Therapeutic Class, by Formulation: Global Opportunity Analysis...

CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd. - Vimarsana News

CSL Behring AG publishes Offer Prospectus on public tender offer for all publicly held shares of Vifor Pharma Ltd.

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220117005418/en/ AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Behring